Drug dis

Safety Pharmacology for the 21st Century – new technologies and approaches supporting safety and predictivity within drug discovery and development

  • Chair(s):

    Helen Prior
    Programme Manager, Drug Development,National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs), London, United Kingdom ,

    Todd Wisialowski
    Associate Research Fellow,Pfizer Inc, Groton, The United States of America , 3 0 President,Safety Pharmacology Society, Groton, The United States of America

  • Session description:

    Advances in Safety Pharmacology for improved risk assessment and translation of cardiovascular and CNS adverse events
    Mr Todd Wisialowski
    SPS President (2022), Pfizer, Groton, The United States of America
    2022 President, Safety Pharmacology Society, Groton, The United States of America

    Innovative models for in vitro detection of seizure
    Dr Kimberley Rockley
    Research Fellow, ApconiX, Alderley Edge, United Kingdom

    Oral communication speaker to be confirmed in 2022.

    Use of computational approaches to identify cardiotoxicity risk
    Dr Cristian Trovato
    University of Oxford United Kingdom, Oxford, United Kingdom

    Integration of multiple endpoints into the same animal model or toxicology studies
    Dr Francesca Pibiri
    J&J Belgium, Beers, Belgium

  • 00

    days

  • 00

    hours

  • 00

    minutes

  • 00

    seconds

Date

03 Jul 2023

Time

9:45 am - 12:10 pm

Speakers

Leave A Comment